China Health Technology Group Holding Company Limited
CHBOF
$0.04
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 89.32% | 44.70% | 6.61% | -7.84% | -22.02% |
| Total Other Revenue | -- | -98.13% | -98.11% | -98.11% | -98.11% |
| Total Revenue | 89.32% | 44.70% | 6.61% | -7.84% | -22.02% |
| Cost of Revenue | 79.19% | 54.15% | 28.97% | 10.95% | -6.86% |
| Gross Profit | 334.65% | -25.59% | -91.11% | -87.32% | -84.22% |
| SG&A Expenses | -27.65% | -13.87% | -0.58% | 4.97% | 10.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.54% | 31.22% | 18.91% | 9.05% | -1.72% |
| Operating Income | 60.20% | 9.64% | -71.55% | -99.19% | -139.79% |
| Income Before Tax | -88.49% | -93.22% | -98.10% | 11.57% | 2,144.85% |
| Income Tax Expenses | 5,350.00% | -74.10% | -95.39% | -97.48% | -99.61% |
| Earnings from Continuing Operations | -88.65% | -93.29% | -98.12% | 13.38% | 1,874.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.65% | -93.29% | -98.12% | 13.38% | 1,874.53% |
| EBIT | 60.20% | 9.64% | -71.55% | -99.19% | -139.79% |
| EBITDA | 60.94% | 10.43% | -70.13% | -97.34% | -137.16% |
| EPS Basic | -91.55% | -94.33% | -98.12% | 152.71% | 412.24% |
| Normalized Basic EPS | 62.46% | 88.17% | 90.59% | 91.53% | 92.36% |
| EPS Diluted | -91.55% | -94.33% | -98.12% | 152.71% | 412.24% |
| Normalized Diluted EPS | 62.46% | 88.17% | 90.59% | 91.53% | 92.36% |
| Average Basic Shares Outstanding | 22.96% | 51.85% | 104.45% | 197.56% | 509.04% |
| Average Diluted Shares Outstanding | 22.96% | 51.85% | 104.45% | 197.56% | 509.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |